Author Archives: Rene Russo

By René Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC I had the opportunity to witness true courage as I met Chrissy Harding several times before she passed away from advanced lung cancer.

By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches features of LifeSciVC When your team’s priority is to execute a well-formed plan, then a “heads down” focus is critical. We all recognize this situation, using

Co-authored by Jodie Morrison and René Russo, former CEO of Cadent Therapeutics and CEO of Xilio Therapeutics, respectively.   Over the last 5 years, biotech executives have been increasingly focused on the importance of greater diversity in our companies. As two

By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC.  If we could quantify the time and money impact of the resources invested in quarterly Board meeting preparation, I wonder if we would

By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC Prioritization is a concept that we have become intimately aware of, given the continually blurred lines of personal and professional obligations in a

This blog was written by Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC. A lifetime ago, in May 2020, I had the honor of writing my first “From the Trenches” blog. I

This blog was written by Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC. In an environment where senior leaders are tasked with defining agile strategies in uncertain times, there are many perspectives